epirubicin has been researched along with Leukemia, Prolymphocytic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergmann, L; Chow, KU; Cordes, HJ; Kim, SZ; Schlegelberger, B; Stilgenbauer, S; von Neuhoff, N; Wunderle, L | 1 |
Bisail, M; Cassisa, L; Casula, S; Fele, G; Malavasi, A; Manca, M | 1 |
1 trial(s) available for epirubicin and Leukemia, Prolymphocytic
Article | Year |
---|---|
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Female; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Male; Middle Aged; Prospective Studies; Rituximab; Vidarabine | 2011 |
1 other study(ies) available for epirubicin and Leukemia, Prolymphocytic
Article | Year |
---|---|
[Discordance between clinical and immunological aspects in a case of chronic B-type lymphoproliferative syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Chronic Disease; Cyclophosphamide; Epirubicin; Female; Humans; Leukemia, Prolymphocytic; Phenotype; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Stereoisomerism; Vincristine | 1991 |